BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) posted its earnings results on Friday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.
BioNxt Solutions Stock Performance
OTCMKTS BNXTF opened at $0.30 on Friday. The firm’s fifty day moving average price is $0.35 and its two-hundred day moving average price is $0.42. The stock has a market cap of $36.39 million, a PE ratio of -5.94 and a beta of 0.69. BioNxt Solutions has a fifty-two week low of $0.14 and a fifty-two week high of $0.80.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Read More
- Five stocks we like better than BioNxt Solutions
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
